One Plus One Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-600
Closed -$468K 99
2025
Q2
$468K Hold
600
0.25% 64
2025
Q1
$496K Sell
600
-94
-14% -$78.2K 0.27% 62
2024
Q4
$536K Hold
694
0.31% 57
2024
Q3
$615K Sell
694
-206
-23% -$185K 0.36% 56
2024
Q2
$815K Hold
900
0.47% 44
2024
Q1
$700K Hold
900
0.4% 51
2023
Q4
$525K Hold
900
0.32% 53
2023
Q3
$483K Hold
900
0.31% 52
2023
Q2
$422K Hold
900
0.27% 58
2023
Q1
$309K Sell
900
-60
-6% -$20.2K 0.22% 68
2022
Q4
$351K Hold
960
0.25% 64
2022
Q3
$310K Hold
960
0.25% 61
2022
Q2
$311K Hold
960
0.24% 68
2022
Q1
$275K Hold
960
0.18% 74
2021
Q4
$265K Hold
960
0.18% 81
2021
Q3
$222K Hold
960
0.16% 79
2021
Q2
$220K Buy
+960
New +$193K 0.15% 78

Other funds holding LLY

One Plus One Wealth Management's LLY Position: Q3 2025 in Review

One Plus One Wealth Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 600 shares — an estimated $468K sold.

One Plus One Wealth Management first reported a position in LLY in Q2 2021 and held it in 17 quarters. The position peaked at $815K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • One Plus One Wealth Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • One Plus One Wealth Management sold 600 Eli Lilly shares in Q3 2025, an estimated $468K.
  • One Plus One Wealth Management first reported a position in Eli Lilly in Q2 2021 and held it in 17 quarters.
  • One Plus One Wealth Management's Eli Lilly position peaked at $815K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on One Plus One Wealth Management's 13F filing for Q3 2025, filed 16 Oct 2025.